TABLE 2.
Association between plasma miR‐205‐5p levels and clinicopathological characteristics in patients with NSCLC
Group | n | Median | (P 25, P 75) | p value a | |
---|---|---|---|---|---|
Gender | |||||
Male | 33 | 3.479 g | (1.639, 8.840) | 0.045 | |
Female | 33 | 2.033 | (1.372,3.620) | ||
Age | |||||
≥62 | 37 | 2.055 | (1.179, 6.350) | 0.361 | |
<62 | 29 | 2.991 | (1.650, 5.581) | ||
Smoking history | |||||
Yes | 21 | 5.419 | (1.650,8.841) | 0.036 | |
No | 45 | 2.157 | (1.162,4.316) | ||
Alcohol history | |||||
Yes | 14 | 6.183 | (1.896,9.024) | 0.047 | |
No | 52 | 2.155 | (1.324,4.535) | ||
Pathological type | |||||
Adenocarcinomas | 42 | 2.101 | (1.377,4.403) | ||
Squamous cell carcinomas | 24 | 3.810 | (1.559,8.868) | 0.131 | |
TNM stage | |||||
I–II | 19 | 2.607 | (1.235,4.956) | ||
III–IV | 41 | 2.907 | (1.615,7.020) | 0.364 | |
Unclear | 6 | 1.628 | (1.581,1.937) |
Wilcoxon rank sum exact test or Kruskal–Wallis rank sum test.